Next, we inspected CHK1 and CHK2 expression levels in specific datasets for ERα-negative and ERα-positive tumors provided by the BC quantitative proteome and proteogenomic landscape (https://www.breastcancerlandscape.org/). The gene discussed is ESR1; the disease is breast cancer.